References
- Arner S, Meyerson BA. Lack of analgesic effects of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11–23
- Caldwell GW, Ritchie DM, Masucci JA, Hageman W, Yan Z. The new pre-preclinical paradigm: Compound optimization in early and late phase drug discovery. Current Topics in Medicinal Chemistry 2001; 1: 353–366
- Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chromic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 2004; 108: 17–27
- Chenard B, Bordner J, Butler TW, Chambers LK, Collins MA, De Costa DL, Ducat MF, Dumont ML, Fox CB, Mena EE, et al. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propranol: A potent new neuroprotectant. which blocks N-methyl-D-aspartate responses. Journal of Medicinal Chemistry 1995; 38: 3138–3145
- Grimwood S, Gilbert E, Ragan CI, Hutson PH. Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites. Journal of Neurochemistry 1996; 66: 2589–2595
- Jonsson M, Lind J, Merenyi G. Redox and acidity properties of 2,2′- and 4,4′-biphenol and the corresponding phenoxyl radicals. Journal of Physical Chemistry A 2002; 106: 4758–4762
- Kristensen JD, Svensson B, Gordh T, Jr. The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans. Pain 1992; 51: 249–253
- Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side-effects in postherpetic neuralgia: A single-dose study clonidine, codeine, ibuprofen and placebo. Clinical Pharmacology and Therapeutics 1988; 43: 363–371
- Pylypenko O, Vitali F, Zerbe K, Robinson JA. Crystal structure of OxyC, a cytochrome P450 implicated in an oxidative C-C coupling reaction during vancomycin biosynthesis. Journal of Biological Chemistry 2003; 278(47)46727–46733
- Stadler R, Zenk MH. The purification and characterization of a unique cytochrome P-450 enzyme from Berberis stolonifera plant cell cultures. Journal of Biological Chemistry 1993; 268(2)823–831
- Trube G, Ehrhard P, Malherbe P, Huber G. The selectivity of Ro 25-6981 for NMDA receptor subtypes expressed in Xenopus oocytes. Society for Neuroscience Abstracts 1996; 22: 693–694
- Whiting PJ, Priestley T. The molecular biology of NMDA type glutamate receptors. Frontiers of Neurobiology 3: Amino acid neurotransmission, AJ Turner, FA Stephenson. Portland, London 1996; 153–176
- Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Molecular Pharmacology 1993; 44: 851–859
- Ye M, Schuler RH. Second-order combination reactions of phenoxyl radicals. Journal of Physical Chemistry 1989; 93: 1898–1902
- Zerbe K, Pylypenko O, Vitali F, Zhang W, Rouset S, Heck M, Vrijbloed JW, Bischoff D, Bister B, Sussmuth RD, et al. Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis. Journal of Biological Chemistry 2002; 277(49)47476–47485
- Zhao B, Guengerich FP, Bellamine A, Lamb DC, Izumikawa M, Lei L, Podust LM, Sundaramoorthy M, Kalaitzis JA, Reddy LM, et al. Binding of two flaviolin substrate molecules, oxidative coupling and crystal structure of Streptomyces coelicolor A3 (2) cytochrome P450 158A2. Journal of Biological Chemistry 2005; 280(12)11599–11607